Best for
Mobile

Posted
Venture Life Group plc is a drug manufacturers-specialty & generic business based in the UK. Venture Life Group shares (VLG.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Venture Life Group employs 101 staff and has a trailing 12-month revenue of around £27.7 million.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Latest market close | N/Ap |
---|---|
52-week range | 19.9723p - 117.8365p |
50-day moving average | 91.6894p |
200-day moving average | 90.9023p |
Wall St. target price | 83p |
PE ratio | 30.1667 |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | 3p |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Venture Life Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Venture Life Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Venture Life Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 30x. In other words, Venture Life Group shares trade at around 30x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Venture Life Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £4.7 million.
The EBITDA is a measure of a Venture Life Group's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | £27.7 million |
---|---|
Operating margin TTM | 13.97% |
Gross profit TTM | £8 million |
Return on assets TTM | 4.79% |
Return on equity TTM | 8.46% |
Profit margin | 10.22% |
Book value | 0.42p |
Market capitalisation | £113.9 million |
TTM: trailing 12 months
We're not expecting Venture Life Group to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Over the last 12 months, Venture Life Group's shares have ranged in value from as little as 19.9723p up to 117.8365p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Venture Life Group's is 0.3182. This would suggest that Venture Life Group's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, and dermo-cosmetics for the ageing population in the United Kingdom, Italy, Switzerland, rest of Europe, and internationally. It operates through Brands, and Development and Manufacturing segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance mental alertness, cognitive function, and mental performance in ageing brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX Original and UltraDEX Sensitive for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and mouth; and Procto-eze for anal irritation, including haemorrhoids conditions. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. Venture Life Group plc sells its products through a network of healthcare partners, as well as grocery multiple retailers. The company was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.